Morocco recovered from Cody Gakpo's opener to beat Netherlands on penalties in a gripping Round of 32 tie. Morocco booked their place in the FIFA World Cup 2026™ Round of 16 after edging past ...
Game summary of the Racing (Montevideo) vs. Progreso Liga Auf Uruguaya game, final score 0-0, from September 29, 2025 on ESPN.
Portugal continue their push for 2026 FIFA World Cup qualification with a trip to Hungary on September 9. Roberto Martinez's team kicked off their Group F campaign in style with a dominant 5-0 win ...
Game summary of the Danubio vs. Progreso Liga Auf Uruguaya game, final score 1-2, from May 30, 2026 on ESPN.
Please provide your email address to receive an email when new articles are posted on . Ixekizumab plus tirzepatide improved skin clearance and body weight in people with difficult-to-treat psoriasis ...
There's probably a lot of you gamers out there on older graphics card pondering an upgrade. Is it worth it? Or is it a waste of money? Well, in an attempt to answer that question for a fair few of you ...
Abstract: Concrete compressive strength is a critical parameter influencing the structural integrity, safety and durability of buildings. This study proposes a data-driven framework to predict ...
Among patients with psoriasis who switched to guselkumab, treatment persistence was 190%, 78%, and 187% more likely at 12 months compared with those who switched to tumor necrosis factor inhibitors, ...
Bimekizumab is associated with significant improvements in pruritus, skin pain, scaling, skin clearance, and quality of life through 3 years of treatment in those with plaque psoriasis. Bimekizumab ...
Please provide your email address to receive an email when new articles are posted on . Two phase 3 studies evaluated efficacy and safety of zasocitinib for plaque psoriasis. About 70% of participants ...
DENVER -- Adding a GLP-1 agonist to psoriasis medication significantly improved outcomes in patients with psoriatic arthritis (PsA) and overweight or obesity, a phase III randomized trial showed.
FDA authorization covers moderate-to-severe plaque psoriasis in adults and patients aged ≥12 years, expanding systemic options for adolescents. Icotrokinra is characterized as a first-in-class ...